Answers are grounded in this paper and cite their sources.
Significance Inhibitors of dengue virus, a mosquito-borne pathogen, are urgently needed. Virally encoded NS2B/3, a two-subunit serine proteinase, is responsible for many cleavages within the viral polyprotein. We demonstrate that two cleavage sites flanking NS3 and one that is internal are self-processing. This strict intramolecular cleavage dictates that, if uncleaved precursors can inhibit viral growth, this phenotype will be trans -dominant. Indeed, a mutation that abrogates one of the self-processing sites caused trans -dominant inhibition of wild-type virus. This site is also the most susceptible to a dengue proteinase inhibitor, providing a compelling rationale for its efficacy. We suggest that explicit targeting of specific intramolecular cleavage sites will be an effective antiviral strategy that can suppress multiple variants in an intracellular quasispecies.
No takes yet. Share an insight, caveat, or question.
Constant et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: